Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339,200,672
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
139,011,387
-
Shares change
-
+1,627,241
-
Total reported value, excl. options
-
$250,194,724
-
Value change
-
+$3,219,600
-
Number of buys
-
50
-
Number of sells
-
-53
-
Price
-
$1.80
Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q2 2023
138 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q2 2023.
Nuvation Bio Inc. - Common Stock (NUVB) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 139,011,387 shares
of 339,200,672 outstanding shares and own 41% of the company stock.
Largest 10 shareholders include FMR LLC (32,670,558 shares), Omega Fund Management, LLC (15,072,340 shares), EcoR1 Capital, LLC (13,896,543 shares), BlackRock Inc. (13,427,374 shares), Deep Track Capital, LP (7,720,688 shares), VANGUARD GROUP INC (7,279,040 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5,854,860 shares), BRAIDWELL LP (4,122,900 shares), ABRAMS CAPITAL MANAGEMENT, L.P. (3,811,513 shares), and Redmile Group, LLC (3,031,009 shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.